New monoclonal antibody inhibits tumour growth in advanced solid tumours in a phase I clinical trial
Tuesday, November 6, 2012 - 20:20
in Health & Medicine
A newly developed antibody targeting a signalling pathway that is frequently active in solid tumors has shown encouraging signs of efficacy in its first trial in humans, researchers report.